1Park S, Kelaidi C, Sapena R, et al. Early introduction of ESA in low risk MDS patients may delay the need for RBC transfusion:a retro- spective analysis on 112 patients [ J ]. Leuk Res, 2010,34 ( 11 ) : 1430 - 1436.
2Balleari E, Clavio M, Arboscello E, et al. Weekly standard doses of rh-EPO are highly effective for the treatment of anemic patients with low-intermediate 1 risk myelodysplastic syndromes [ J ]. Leuk Res, 2011,35 ( 11 ) : 1472 - 1476.
3Corbin AS, Agarwal A, Loriaux M, et al. Human chronic myeloid leu- kemia stem cells are insensitive to imatinib despite inhibition of BCR -ABL activity [ J ]. J Clin Invest,201 !, 121 ( 1 ) :396 - 409.
4Mirhendi H, Bruun B, Schonheyder HC, et al. Molecular screening for Candida orthopsilosis and Candida metapsilosis among Danish Candida parapsilosis group blood culture isolates:proposal of a new RFLP profile for differentiation [ J ]. J Med Microbiol, 2010,59 ( Pt 4) :414 -420.
10Moosbauer C,Morgenstem E,Cuvelier SL,et al.EosinopNIs are a major inmvascular location for tissue factor storage and exposure[J].Bood, 2007,109(5):995-1002.
